Tue, Aug 20 2:57pm

New 52 Week Lows (1)

Nektar Therapeutics [NKTR]
$17.22 0.65 (3.64%)

NKTR Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 3.17 Billion
NKTR Description

Nektar Therapeutics is a San Francisco-based emerging biotechnology company specializing in PEGylation technology. Its portfolio includes PEGylated biologics in immuno-oncology, chronic pain, hemophilia, breast cancer, and autoimmune disease. The company partners with several large pharmaceutical and biotechnology companies to co-develop therapies in a range of indications, which includes a collaboration with Bristol-Myers Squibb to develop bempegaldesleukin, the firm's leading immuno-oncology candidate, in combination with Bristol's Opdivo.


Visit Website

NKTR Earnings

EPS -0.63 P/E Ratio 8.20
Previous Earnings Wed, May 8, 2019
Latest Earnings Thu, Aug 8, 2019 (12 days ago) -39.97%

NKTR Dividend

Yield --
Ex-Date --
Pay Date --
History --

NKTR Charts

$17.21
1 Year
$68.60
Aug 20, 2019
Sep 4, 2018



Symbol Price Day % YTD %
NKTR $17.22 -3.64% -49.68%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy